January 8, 2025

Arcadium Lithium (ALTM) Shares Climb On Acquisition Progress

Arcadium Lithium plc (NYSE: ALTM) shares soared in pre-market trading today, climbing 8.61% to $5.72 following significant regulatory progress for its proposed acquisition by Rio Tinto. Global Merger Clearances Advance Deal After reviewing the transaction, the Committee on Foreign Investment in the United States (CFIUS) decided that there are no outstanding national security issues. This …

Arcadium Lithium (ALTM) Shares Climb On Acquisition Progress Read More »

CURRENC Group Shares Soar In Pre-Market Trading After AI Launch

CURRENC Group Inc. (NASDAQ: CURR) witnessed a remarkable surge in its stock value today following the announcement of its latest AI-based solution. In pre-market trading, CURR stock soared by 123.01%, reaching $3.10. This significant market response highlights growing investor confidence in the company’s innovative strides. Introduction of SEAMLESS AI Call Centre Solutions CURRENC, formerly known …

CURRENC Group Shares Soar In Pre-Market Trading After AI Launch Read More »

After-Hour Trading Boosts Strawberry Fields (STRW) Stock

Strawberry Fields REIT, Inc. (NYSE: STRW) saw its stock soar during after-hours trading on Tuesday, climbing 10.20% to $11.99 following a 5.84% regular-session increase closing at $10.88. The upward momentum was driven by a business update revealing a series of strategic acquisitions. Strategic Purchases Increase Portfolio Size Strawberry Fields (STRW) completed the $24 million purchase …

After-Hour Trading Boosts Strawberry Fields (STRW) Stock Read More »

Gain Therapeutics (GANX) Shares Rise In After-Hour Trading

After the announcement of a leadership change, shares of Gain Therapeutics, Inc. (NASDAQ: GANX) surged sharply on the US stock charts. In after-hours trading, GANX stock jumped 14.18%, trading at $2.59. The company announced Gene Mack as its president and CEO, effective January 6, 2025. Gene Mack Takes the Lead The dual roles of CEO …

Gain Therapeutics (GANX) Shares Rise In After-Hour Trading Read More »

FDA Nod Sends Solid Biosciences (SLDB) Soaring In Extended Session

Following a crucial regulatory milestone, Solid Biosciences Inc. (NASDAQ: SLDB) saw a notable increase in the value of its shares. Tuesday’s after-hours trade saw SLDB shares increase 17.35% to $4.60. The spike was propelled by the FDA’s approval of Investigational New Drug or IND application for SGT-212, the company’s new gene therapy candidate that targets …

FDA Nod Sends Solid Biosciences (SLDB) Soaring In Extended Session Read More »